The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
Open accessAbstract
SUMMARY Bromodomain-containing protein 4 (Brd4) is an epigenetic reader and transcriptional regulator recently identified as a cancer therapeutic target for acute myeloid leukemia, multiple myeloma, and Burkitt's lymphoma. Although chromatin targeting is a crucial function of Brd4, there is little understanding of how bromodomains that bind acetylated histones are regulated, nor how the gene-specific activity of Brd4 is determined. Via interaction screen and domain mapping, we identified p53 as a functional partner of Brd4. Interestingly, Brd4 association with p53 is modulated by casein kinase II (CK2)-mediated phosphorylation of a conserved acidic region in Brd4 that selectively contacts either a juxtaposed bromodomain or an adjacent basic region to dictate the ability of Brd4 binding to chromatin and also the recruitment of p53 to regulated promoters. The unmasking of bromodomains and activator recruitment, concurrently triggered by the CK2 phospho switch, provide an intriguing mechanism for gene-specific targeting by a universal epigenetic reader.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K., & Miyawaki, A. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-87 · Cited by 2,753
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,694
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C.-W., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,503
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation
Wu, S.-Y., & Chiang, C.-M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700001200 · Cited by 679
Self-citationThe double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., & Ozato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433065100 · Cited by 669
Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 644
Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-10 · Cited by 532
Phair, R. D., Scaffidi, P., Elbi, C., Vecerová, J., Dey, A., Ozato, K., Brown, D. T., Hager, G., Bustin, M., & Misteli, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6393-6402.2004 · Cited by 452
Zippo, A., Serafini, R., Rocchigiani, M., Pennacchini, S., Krepelova, A., & Oliviero, S. (2009) · Cell · doi:10.1016/j.cell.2009.07.031 · Cited by 411
Casein Kinase IIα Transgene-Induced Murine Lymphoma: Relation to Theileriosis in Cattle
Seldin, D. C., & Leder, P. (1995) · Science · doi:10.1126/science.7846532 · Cited by 395
Sarno, S., Reddy, H., Meggio, F., Ruzzene, M., Davies, S. P., Donella-Deana, A., Shugar, D., & Pinna, L. A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02404-8 · Cited by 356
Yang, Z., He, N., & Zhou, Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01020-07 · Cited by 347
Pathogenesis of NUT Midline Carcinoma
French, C. A. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132438 · Cited by 264
Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation
Zhao, R., Nakamura, T., Fu, Y., Lazar, Z., & Spector, D. L. (2011) · Nature Cell Biology · doi:10.1038/ncb2341 · Cited by 253
Brd4 links chromatin targeting to HPV transcriptional silencing
Wu, S.-Y., Lee, A.-Y., Hou, S. Y., Kemper, J. K., Erdjument-Bromage, H., Tempst, P., & Chiang, C.-M. (2006) · Genes & Development · doi:10.1101/gad.1448206 · Cited by 210
Self-citationThomas, M. C., & Chiang, C.-M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.016 · Cited by 178
Self-citationChiang, C. (2009) · F1000 Biology Reports · doi:10.3410/b1-98 · Cited by 150
Self-citationWu, S., & Chiang, C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.83 · Cited by 125
Ramirez, R. D., Herbert, B., Vaughan, M. B., Zou, Y. S., Gandia, K., Morales, C. P., Wright, W. E., & Shay, J. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206046 · Cited by 107
Levens, D. (2010) · Genes & Cancer · doi:10.1177/1947601910377492 · Cited by 93
Alsarraj, J., Walker, R. C., Webster, J. D., Geiger, T. R., Crawford, N. P. S., Simpson, R. J., Ozato, K., & Hunter, K. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4417 · Cited by 81
Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability
Lee, A.-Y., & Chiang, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805835200 · Cited by 76
Self-citationCdk9 phosphorylates p53 on serine 392 independently of CKII
Claudio, P. P., Cui, J., Ghafouri, M., Mariano, C., White, M. K., Safak, M., Sheffield, J. B., Giordano, A., Khalili, K., Amini, S., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20698 · Cited by 51
Wang, W., Wu, S.-Y., Lee, A.-Y., & Chiang, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290874 · Cited by 43
Self-citationIdentification of HEXIM1 as a Positive Regulator of p53
Lew, Q. J., Chia, Y. L., Chu, K. L., Lam, Y. T., Gurumurthy, M., Xu, S., Lam, K., Cheong, N., & Chao, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374157 · Cited by 37
Cited by
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation
Zhou, H.-X., & Pang, X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00305 · Cited by 1,190
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Asangani, I. A., Dommeti, V. L., Wang, X., Malik, R., Cieslik, M., Yang, R., Escara-Wilke, J., Wilder-Romans, K., Dhanireddy, S., Engelke, C., et al. (2014) · Nature · doi:10.1038/nature13229 · Cited by 927
BRD4 and Cancer: going beyond transcriptional regulation
Donati, B., Lorenzini, E., & Ciarrocchi, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0915-9 · Cited by 708
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature · doi:10.1038/nature16508 · Cited by 632
Self-citation
Metadata
- Authors
- Wu, S.-Y., Lee, A.-Y., Lai, H.-T., Zhang, H., & Chiang, C.-M.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 49
- Issue
- 5
- Pages
- 843-857
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2051959262
- Cited by
- 347
- References
- 28
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.